Year archive

Genmab — 2021 filings

All 226 regulatory filings released by Genmab (GMAB) in 2021, sourced directly from the official regulator.

226 Filings

2021 Period

2021 filings (226)

Filing	Released	Lang
6-K Foreign Filer Report	2021-12-15	English
6-K Foreign Filer Report	2021-12-14	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-12-14	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-12-14	English
6-K Foreign Filer Report	2021-12-01	English
6-K Foreign Filer Report	2021-11-22	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-11-22	English
Director's Dealing 2021 Director's Dealing	2021-11-22	English
6-K Foreign Filer Report	2021-11-17	English
6-K Foreign Filer Report	2021-11-16	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-11-16	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-11-16	English
6-K Foreign Filer Report	2021-11-10	English
6-K Foreign Filer Report	2021-11-04	English
Genmab Improves its 2021 Financial Guidance Earnings Release FY 2021	2021-11-04	English
Earnings Release 2021 Earnings Release FY 2021	2021-11-04	English
6-K Foreign Filer Report	2021-10-19	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2021 Earnings Release Q3 2021	2021-10-19	English
Earnings Release 2021 Earnings Release Q3 2021	2021-10-19	English
6-K Foreign Filer Report	2021-10-15	English
6-K Foreign Filer Report	2021-10-07	English
6-K Foreign Filer Report	2021-09-22	English
6-K Foreign Filer Report	2021-09-21	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-09-21	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-09-21	English
6-K Foreign Filer Report	2021-09-20	English
Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer Regulatory Filings	2021-09-20	English
Earnings Release 2021 Earnings Release Q3 2021	2021-09-20	English
6-K Foreign Filer Report	2021-08-18	English
6-K Foreign Filer Report	2021-08-17	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-08-17	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-08-17	English
6-K Foreign Filer Report	2021-08-11	English
Report Publication Announcement 2021 Report Publication Announcement H1 2021	2021-08-11	English
Interim / Quarterly Report 2021 Interim / Quarterly Report H1 2021	2021-08-11	English
6-K Foreign Filer Report	2021-07-21	English
Major Shareholder Announcement Major Shareholding Notification	2021-07-21	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-07-21	English
6-K Foreign Filer Report	2021-07-21	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2021 Earnings Release Q2 2021	2021-07-21	English
Earnings Release 2021 Earnings Release Q2 2021	2021-07-21	English
6-K Foreign Filer Report	2021-07-07	English
6-K Foreign Filer Report	2021-07-06	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-07-06	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-07-06	English
6-K Foreign Filer Report	2021-07-01	English
6-K Foreign Filer Report	2021-07-01	English
Completion of share buy-back program Transaction in Own Shares	2021-07-01	English
Completion of share buy-back program Transaction in Own Shares	2021-07-01	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-07-01	English
6-K Foreign Filer Report	2021-06-28	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-28	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-28	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-28	English
6-K Foreign Filer Report	2021-06-22	English
6-K Foreign Filer Report	2021-06-22	English
Genmab Announces that Janssen has Received European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous Formulation, Including for the Treatment of Patients with Newly Diagnosed Light-ch Regulatory Filings	2021-06-22	English
Regulatory Filings 2021 Regulatory Filings	2021-06-22	English
6-K Foreign Filer Report	2021-06-21	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-21	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-21	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-21	English
6-K Foreign Filer Report	2021-06-16	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-06-16	English
Director's Dealing 2021 Director's Dealing	2021-06-16	English
6-K Foreign Filer Report	2021-06-14	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-14	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-14	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-14	English
6-K Foreign Filer Report	2021-06-10	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-06-10	English
Director's Dealing 2021 Director's Dealing	2021-06-10	English
6-K Foreign Filer Report	2021-06-07	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-07	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-06-07	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-06-07	English
6-K Foreign Filer Report	2021-06-01	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-31	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-31	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-31	English
6-K Foreign Filer Report	2021-05-25	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-25	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-25	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-25	English
6-K Foreign Filer Report	2021-05-21	English
6-K Foreign Filer Report	2021-05-21	English
Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) Subcutaneous (SC) Formulation for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis Regulatory Filings	2021-05-21	English
Regulatory Filings 2021 Regulatory Filings	2021-05-21	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-05-21	English
Director's Dealing 2021 Director's Dealing	2021-05-21	English
6-K Foreign Filer Report	2021-05-19	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-05-19	English
Director's Dealing 2021 Director's Dealing	2021-05-19	English
6-K Foreign Filer Report	2021-05-17	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-17	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-17	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-17	English
6-K Foreign Filer Report	2021-05-12	English
6-K Foreign Filer Report	2021-05-12	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-05-12	English
Director's Dealing 2021 Director's Dealing	2021-05-12	English
6-K Foreign Filer Report	2021-05-11	English
Director's Dealing 2021 Director's Dealing	2021-05-11	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-05-11	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-05-11	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-05-11	English
6-K Foreign Filer Report	2021-05-10	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-10	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-10	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-05-10	English
6-K Foreign Filer Report	2021-05-07	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-05-07	English
Director's Dealing 2021 Director's Dealing	2021-05-07	English
6-K Foreign Filer Report	2021-05-05	English
6-K Foreign Filer Report	2021-05-03	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-05-03	English
Director's Dealing 2021 Director's Dealing	2021-05-03	English
6-K Foreign Filer Report	2021-05-03	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-03	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-05-03	English
Regulatory Filings 2021 Regulatory Filings	2021-05-03	English
6-K Foreign Filer Report	2021-04-26	English
6-K Foreign Filer Report	2021-04-26	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-26	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-26	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-04-26	English
6-K Foreign Filer Report	2021-04-20	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021 Earnings Release Q1 2021	2021-04-20	English
Earnings Release 2021 Earnings Release Q1 2021	2021-04-20	English
6-K Foreign Filer Report	2021-04-19	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-19	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-19	English
Regulatory Filings 2021 Regulatory Filings	2021-04-19	English
6-K/A Foreign Filer Report	2021-04-15	English
6-K Foreign Filer Report	2021-04-13	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-04-13	English
Director's Dealing 2021 Director's Dealing	2021-04-13	English
6-K Foreign Filer Report	2021-04-13	English
6-K Foreign Filer Report	2021-04-12	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-04-12	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-12	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-12	English
6-K Foreign Filer Report	2021-04-09	English
Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer Regulatory Filings	2021-04-09	English
Regulatory Filings 2021 Regulatory Filings	2021-04-09	English
6-K Foreign Filer Report	2021-04-06	English
Regulatory Filings 2021 Regulatory Filings	2021-04-06	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-06	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-04-06	English
6-K Foreign Filer Report	2021-03-30	English
Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis Regulatory Filings	2021-03-30	English
Regulatory Filings 2021 Regulatory Filings	2021-03-30	English
20-F Annual Report FY 2020	2021-03-29	English
6-K Foreign Filer Report	2021-03-29	English
Transactions in connection with share buy-back program Regulatory Filings	2021-03-29	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-29	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-29	English
6-K Foreign Filer Report	2021-03-22	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-22	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-22	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-22	English
6-K Foreign Filer Report	2021-03-15	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-15	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-15	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-15	English
6-K Foreign Filer Report	2021-03-09	English
6-K Foreign Filer Report	2021-03-08	English
6-K Foreign Filer Report	2021-03-08	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-08	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-08	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-08	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-03-07	English
Director's Dealing 2021 Director's Dealing	2021-03-07	English
6-K Foreign Filer Report	2021-03-03	English
6-K Foreign Filer Report	2021-03-02	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-03-02	English
Director's Dealing 2021 Director's Dealing	2021-03-02	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-03-02	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2021-03-02	English
6-K Foreign Filer Report	2021-03-02	English
6-K Foreign Filer Report	2021-03-01	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-01	English
Transactions in connection with share buy-back program Transaction in Own Shares	2021-03-01	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-03-01	English
6-K Foreign Filer Report	2021-02-26	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-02-26	English
Director's Dealing 2021 Director's Dealing	2021-02-26	English
REGISTRATION STATEMENT Registration Form	2021-02-25	English
6-K Foreign Filer Report	2021-02-25	English
Director's Dealing 2021 Director's Dealing	2021-02-25	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-02-25	English
6-K Foreign Filer Report	2021-02-23	English
6-K Foreign Filer Report	2021-02-23	English
Genmab announces initiation of share buy-back program Transaction in Own Shares	2021-02-23	English
Transaction in Own Shares 2021 Transaction in Own Shares	2021-02-23	English
Annual Report 2020 Annual Report FY 2020	2021-02-23	English
Genmab Publishes 2020 Annual Report Report Publication Announcement	2021-02-23	English
Annual Report 2020 Annual Report FY 2020	2021-02-23	English
6-K Foreign Filer Report	2021-02-22	English
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines Board/Management Information	2021-02-22	English
Board/Management Information 2021 Board/Management Information	2021-02-22	English
6-K Foreign Filer Report	2021-02-10	English
Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer Regulatory Filings	2021-02-10	English
Legal Proceedings Report 2021 Legal Proceedings Report	2021-02-10	English
6-K Foreign Filer Report	2021-02-05	English
6-K Foreign Filer Report	2021-01-29	English
Regulatory Filings 2021 Regulatory Filings	2021-01-29	English
CHMP Issues Positive Opinion Recommending Ofatumumab in Relapsing Multiple Sclerosis Regulatory Filings	2021-01-29	English
Regulatory Filings 2021 Regulatory Filings	2021-01-29	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-01-29	English
6-K Foreign Filer Report	2021-01-28	English
6-K Foreign Filer Report	2021-01-27	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-01-27	English
Director's Dealing 2021 Director's Dealing	2021-01-27	English
6-K Foreign Filer Report	2021-01-26	English
Earnings Release 2020 Earnings Release FY 2020	2021-01-26	English
Genmab Announces 2020 Net Sales of DARZALEX® (daratumumab) Earnings Release FY 2020	2021-01-26	English
6-K Foreign Filer Report	2021-01-15	English
Regulatory Filings 2021 Regulatory Filings	2021-01-15	English
Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis Regulatory Filings	2021-01-15	English
6-K Foreign Filer Report	2021-01-13	English
Regulatory Filings 2021 Regulatory Filings	2021-01-13	English
Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie Regulatory Filings	2021-01-13	English
6-K Foreign Filer Report	2021-01-05	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2021-01-05	English
Director's Dealing 2021 Director's Dealing	2021-01-05	English

Filings by year

2026 64 filings
2025 190 filings
2024 204 filings
2023 149 filings
2022 190 filings
2021 226 filings
2020 167 filings
2019 213 filings
2018 68 filings
2017 124 filings
2016 229 filings
2015 128 filings
2014 107 filings
2013 132 filings
2012 98 filings
2011 97 filings
2010 133 filings
2009 121 filings
2008 109 filings
2007 70 filings